Table 1 Baseline demographics and history of treatment (n = 99).
Type | Variables | Mean (min, max) or count (%) |
|---|---|---|
Demographics | Age, years | 30.92 (18.00–53.00) |
10–20 | 4 (4.04%) | |
20–30 | 48 (48.48%) | |
30–40 | 38 (38.38%) | |
40–50 | 7 (7.07%) | |
50–60 | 2 (2.02%) | |
Gender | ||
Male | 58 (58.59%) | |
Female | 41 (41.41%) | |
Occupation | ||
Yes | 68 (68.69%) | |
Marriage | ||
Yes | 19 (19.19%) | |
Disease onset | ||
Adult exacerbation | 6 (6.06%) | |
Childhood | 93 (93.94%) | |
Family history of allergy | ||
Yes | 36 (36.36%) | |
Allergy history | 57 (57.58%) | |
Allergic conjunctivitis | 17 (29.82%) | |
Allergic rhinitis | 49 (85.96%) | |
Asthma | 12 (21.05%) | |
Known allergy | 55 (55.56%) | |
House dust mite | 53 (96.36%) | |
Mold | 19 (34.55%) | |
Food | 5 (9.09%) | |
Cat | 6 (10.91%) | |
Dog | 3 (5.45%) | |
History of treatment | Topical treatment | |
Topical steroid | 92 (92.93%) | |
Topical calcineurin inhibitor | 68 (68.69%) | |
Systemic treatment | ||
Systemic steroid | 65 (65.66%) | |
Immunosuppressant | 61 (61.61%) | |
Cyclosporine | 53 (86.89%) | |
Methotrexate | 6 (9.84%) | |
Mycophenolate mofetil | 1 (1.64%) | |
Azathioprine | 1 (1.64%) | |
Phototherapy | 20 (20.20%) | |
Immunotherapy | 13 (13.13%) | |
Oriental medicine | 52 (52.53%) | |
Folk remedy | 27 (27.27%) |
